Imatinib Mesylate Drug Interactions: 218 Major, 677 Moderate
Imatinib Mesylate Drug Interactions
Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Imatinib Mesylate. Always confirm against the full prescribing information.
100 interactions
Abacavir
Imatinib may increase the hepatotoxic activities of Abacavir.
Level 2 evidence
Abatacept
The metabolism of Imatinib can be increased when combined with Abatacept.
Level 1 evidence
Abemaciclib
The serum concentration of Abemaciclib can be increased when it is combined with Imatinib.
Level 1 evidence
Abrocitinib
The metabolism of Abrocitinib can be decreased when combined with Imatinib.
Level 2 evidence
Acalabrutinib
The serum concentration of Acalabrutinib can be increased when it is combined with Imatinib.
Level 1 evidence
Acarbose
Acarbose may increase the hepatotoxic activities of Imatinib.
Level 2 evidence
Acenocoumarol
Imatinib may increase the anticoagulant activities of Acenocoumarol.
Level 1 evidence
Acetazolamide
Imatinib may increase the hepatotoxic activities of Acetazolamide.
Level 2 evidence
Acetylsalicylic acid
The metabolism of Acetylsalicylic acid can be decreased when combined with Imatinib.
Level 2 evidence
Acitretin
Acitretin may increase the hepatotoxic activities of Imatinib.
Level 2 evidence
Acoramidis
The metabolism of Imatinib can be decreased when combined with Acoramidis.
Level 2 evidence
Acrivastine
The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Imatinib.
Level 2 evidence
Enter your NPI to unlock 15 major interactions for Imatinib Mesylate
Imatinib Mesylate has 1187 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Imatinib Mesylate has 218 major, 677 moderate, and 292 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Imatinib Mesylate. Always confirm against the full prescribing information.